Published in Cardiovasc Diabetol on October 10, 2017
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol (2009) 9.40
Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med (2014) 8.73
Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med (2014) 4.88
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009. Eur Heart J (2013) 2.74
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia (2011) 1.94
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 1.80
Time Trends in Ischemic Stroke among Type 2 Diabetic and Non-Diabetic Patients: Analysis of the Spanish National Hospital Discharge Data (2003-2012). PLoS One (2015) 1.43
National trends in incidence and outcomes of abdominal aortic aneurysm among elderly type 2 diabetic and non-diabetic patients in Spain (2003-2012). Cardiovasc Diabetol (2015) 1.42
Predictors of Adherence to Multiple Clinical Preventive Recommendations among Adults with Diabetes in Spain. PLoS One (2015) 1.40
Trends in the incidence of lower extremity amputations in people with and without diabetes over a five-year period in the Republic of Ireland. PLoS One (2012) 1.21
Matched case-control designs and overmatched analyses. Am J Epidemiol (1986) 1.16
Trends in lower-extremity amputations in people with and without diabetes in Spain, 2001-2008. Diabetes Care (2011) 1.12
The disparity in long-term survival after a first stroke in patients with and without diabetes persists: the Northern Sweden MONICA study. Cerebrovasc Dis (2012) 1.10
Systematic review and meta-analysis of validation studies on a diabetes case definition from health administrative records. PLoS One (2013) 1.05
Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction. Circ Cardiovasc Qual Outcomes (2012) 0.99
Coding of obesity in administrative hospital discharge abstract data: accuracy and impact for future research studies. BMC Health Serv Res (2014) 0.99
Time trends in cardiovascular and all-cause mortality in the 'old' and 'new' European Union countries. Eur J Cardiovasc Prev Rehabil (2011) 0.98
Lower extremity amputations in persons with and without diabetes in Italy: 2001-2010. PLoS One (2014) 0.97
Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice. Cardiovasc Diabetol (2016) 0.94
Variation in the recording of common health conditions in routine hospital data: study using linked survey and administrative data in New South Wales, Australia. BMJ Open (2014) 0.94
Trends in Mortality From Ischemic Heart Disease and Cerebrovascular Disease in Europe: 1980 to 2009. Circulation (2016) 0.90
Trends in hypertension prevalence, awareness, treatment and control in an adult type 2 diabetes Spanish population between 2003 and 2009. PLoS One (2014) 0.89
Administrative Databases Can Yield False Conclusions-An Example of Obesity in Total Joint Arthroplasty. J Arthroplasty (2017) 0.89
HbA1c below 7 % as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis. Cardiovasc Diabetol (2015) 0.86
Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study. Cardiovasc Diabetol (2016) 0.85
National trends in rate of patients hospitalized for heart failure and heart failure mortality in France, 2000-2012. Eur J Heart Fail (2015) 0.84
Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials. Cardiovasc Diabetol (2016) 0.82
Comparison of 2-year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: results from the DIAMOND prospective cohort registry. Cardiovasc Diabetol (2015) 0.82
In-hospital mortality among patients with type 2 diabetes mellitus and acute myocardial infarction: results from the national inpatient sample, 2000-2010. J Am Heart Assoc (2014) 0.81
National trends in incidence and outcomes in lower extremity amputations in people with and without diabetes in Spain, 2001-2012. Diabetes Res Clin Pract (2015) 0.81
Impact of diabetes on the predictive value of heart failure biomarkers. Cardiovasc Diabetol (2016) 0.80
Type 2 Diabetes and Hemorrhagic Stroke: A Population-Based Study in Spain from 2003 to 2012. J Stroke Cerebrovasc Dis (2016) 0.80
Mortality after first myocardial infarction in diabetic and non-diabetic people between 1985 and 2009. The MONICA/KORA registry. Eur J Epidemiol (2014) 0.78
Impact of cardiovascular risk factors and disease on length of stay and mortality in patients with acute coronary syndromes. Int J Cardiol (2016) 0.77
European cardiovascular mortality over the last three decades: evaluation of time trends, forecasts for 2016. Ann Ig (2017) 0.77
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes. Eur Heart J Cardiovasc Pharmacother (2017) 0.77
Disease-modifying therapy and hospitalization risk in heart failure patients. Am J Manag Care (2015) 0.76
Mortality in type 2 diabetes patients admitted because of acute heart failure. Rev Clin Esp (2016) 0.76
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk. Cardiovasc Diabetol (2017) 0.75
Beneficial effects through aggressive coronary screening for type 2 diabetes patients with advanced vascular complications. Medicine (Baltimore) (2016) 0.75